
Retatrutide is one of the larger and more structurally intricate peptides in the current UAE research catalogue — a triple agonist engineered to interact with GLP-1, GIP and glucagon receptor pathways, with a molecular weight around 4731 Da. Peptides of this size are built through many sequential coupling steps during synthesis, and each step carries a small chance of an incomplete reaction, a deletion sequence, or a side-chain modification that doesn't fully resolve. None of that is unusual in peptide chemistry — it's why purification and testing exist. The problem is that in an unregulated market, not every supplier actually does the purification and testing rigorously, or discloses the results.
For a research buyer, this means the label on a vial tells you what the seller intends to be inside — not what has been independently confirmed to be inside. That gap is exactly what high-performance liquid chromatography (HPLC) testing and a proper Certificate of Analysis (COA) are meant to close.
Reverse-phase HPLC pushes a dissolved peptide sample through a column packed with a fine stationary material under high pressure. Different components of the sample — the target peptide, any related synthesis byproducts, residual solvents — travel through the column at different speeds based on their chemical properties, and elute (exit) at different times. A detector records each component as a peak on a chromatogram. The size and position of each peak tell a trained analyst two things: identity (does the retention time and peak shape match what's expected for this molecule) and purity (what percentage of the total detected material belongs to the main peak versus everything else).
When REVIVE LAB UAE states Retatrutide is tested to ≥99.0% HPLC purity, that means the main peptide peak accounts for at least 99.0% of the total peak area on the chromatogram for that specific manufacturing lot. It is not a marketing estimate — it is a number generated from an actual analytical run on that batch, and it's the figure that should appear on the COA shipped with the product.
Not every document labelled "COA" is actually useful. A lot-specific Certificate of Analysis for a research peptide like Retatrutide should include, at minimum:
A generic PDF with no lot number, no test date, and language copy-pasted across every product on a supplier's site is not a real COA — it's a template. If the lot number on your vial doesn't match the lot number on the document you were sent, the document is not verifying anything.
The research-peptide supply chain is largely unregulated worldwide, which means there is no automatic enforcement mechanism catching suppliers who sell underdosed, adulterated, or simply mislabeled material. This isn't a hypothetical concern — it's the structural reason COA verification matters as much as it does. Buyers relying on price and packaging alone have no way to know whether what arrives matches what was ordered.
Common red flags worth treating seriously:
Every Retatrutide batch REVIVE LAB UAE stocks is HPLC-tested before it reaches inventory, and every order ships with a lot-specific COA matched to the vial received. The specification for the current product:
| Spec | Retatrutide 10 mg vial |
|---|---|
| Price | AED 449 |
| Molecular weight | ≈4731 Da |
| Purity (HPLC) | ≥99.0% |
| Class | Triple agonist (GLP-1/GIP/GCG) research peptide |
| Documentation | Lot-specific HPLC Certificate of Analysis with every order |
| Form | Lyophilised powder, research use only |
It verifies both identity (does the sample match the expected molecule) and purity (what percentage of the sample is the target peptide versus synthesis byproducts or impurities), based on an actual chromatographic run of that batch.
Product name, lot/batch number, test date, testing method, measured purity percentage, molecular weight confirmation, appearance description, storage recommendation, and a research-use-only statement — all specific to the batch shipped.
Because the research-peptide market is largely unregulated, REVIVE LAB UAE tests every batch to ≥99.0% HPLC purity and issues a matching lot-specific COA so buyers aren't relying on unverified claims.
No COA, prices far below market, no verifiable UAE address, and payment methods with no transaction trail are the clearest warning signs.